Frederick Lam Cohort Four participant

Frederick Lam

The Royal College of Music

Frederick Lam


A web-based application that approaches occupational pain through professional demands and advanced digital pain drawings

Occu-Pain is a web-based mobile platform aimed at reporting occupational pain problems more accurately, providing an alternative to long-awaited in-person pain evaluation. Combining current understanding and knowledge in occupation-specific pain problems into digital pain drawings (PDs), with users providing information on their occupation, specialism and performing behaviours, Occu-Pain provides a tailored evaluation of their pain situations, followed by possible next-step solutions.

Whether the users are waiting for in-person medical assessments, or just want to understand their pain situations better, Occu-Pain offers instant response to their needs. Suiting the busy lifestyle of users and patients, people can reduce their struggle to book a face-to-face medical appointment. Furthermore, considered as a plug-in to the existing health records system, Occu-Pain hopes to help practitioners to understand patients’ causes and problems of pain more efficiently.

Pain issues can impact people in most occupations, and how patients communicate their pain situations accurately is significantly important. It is common that existing pain management apps or GPs can only diagnose patients’ pain problems from a general medical perspective, rather than an integrated diagnosis with their occupational backgrounds. Occu-Pain is a platform to improve communications and expression of patients’ pain problems, in a more personal and convenient manner.

Occu-Pain logo
Occu-Pain logo

Diagnostics Accelerator Programme: market access planning and evidence generation

Delivered in partnership with the National Institute of Health Research London In Vitro Diagnostics unit this six-week evidence generation focused programme will support medtech innovators to de-risk the path to successful deployment through the development of a business case validating their clinical, financial and social claims. This way, when innovators approach the health system, they are comfortable in the knowledge that the product achieves what it is designed to do.

Applications Open (closing 7 March 2021)